Finasteride inhibits melanogenesis through regulation of the adenylate cyclase in melanocytes and melanoma cells
Finasteride is a well-known 5α-reductase inhibitor used for treatment of alopecia and prostate cancer. But the effect of finasteride in regulating melanogenesis is still unclear. In the present study the role of finasteride on melanogenesis was investigated. Finasteride decrease melanin level in mel...
Saved in:
Published in | Archives of pharmacal research Vol. 41; no. 3; pp. 324 - 332 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Seoul
Pharmaceutical Society of Korea
01.03.2018
대한약학회 |
Subjects | |
Online Access | Get full text |
ISSN | 0253-6269 1976-3786 1976-3786 |
DOI | 10.1007/s12272-018-1002-x |
Cover
Abstract | Finasteride is a well-known 5α-reductase inhibitor used for treatment of alopecia and prostate cancer. But the effect of finasteride in regulating melanogenesis is still unclear. In the present study the role of finasteride on melanogenesis was investigated. Finasteride decrease melanin level in melanocyte melan-a cells and B16F10 melanoma cells without inducing cytotoxicity. MC1R (melanocortin 1 receptor) protein expression was also inhibited by finasteride thereby decreasing the expression of adenylate cyclase, MITF (Melanogenesis associated transcription factor), tyrosinases, TRP (tyrosinase-related protein) -1 and -2. Thus our study suggest that finasteride inhibits melanogenesis in melanocyte and melanoma cells by inhibiting MC1R. |
---|---|
AbstractList | Finasteride is a well-known 5a-reductase inhibitorused for treatment of alopecia and prostate cancer. But theeffect of finasteride in regulating melanogenesis is stillunclear. In the present study the role of finasteride onmelanogenesis was investigated. Finasteride decrease melaninlevel in melanocyte melan-a cells and B16F10 melanomacells without inducing cytotoxicity. MC1R (melanocortin 1receptor) protein expression was also inhibited by finasteridethereby decreasing the expression of adenylate cyclase, MITF(Melanogenesis associated transcription factor), tyrosinases,TRP (tyrosinase-related protein) -1 and -2. Thus our studysuggest that finasteride inhibits melanogenesis in melanocyteand melanoma cells by inhibiting MC1R. KCI Citation Count: 10 Finasteride is a well-known 5α-reductase inhibitor used for treatment of alopecia and prostate cancer. But the effect of finasteride in regulating melanogenesis is still unclear. In the present study the role of finasteride on melanogenesis was investigated. Finasteride decrease melanin level in melanocyte melan-a cells and B16F10 melanoma cells without inducing cytotoxicity. MC1R (melanocortin 1 receptor) protein expression was also inhibited by finasteride thereby decreasing the expression of adenylate cyclase, MITF (Melanogenesis associated transcription factor), tyrosinases, TRP (tyrosinase-related protein) -1 and -2. Thus our study suggest that finasteride inhibits melanogenesis in melanocyte and melanoma cells by inhibiting MC1R. Finasteride is a well-known 5α-reductase inhibitor used for treatment of alopecia and prostate cancer. But the effect of finasteride in regulating melanogenesis is still unclear. In the present study the role of finasteride on melanogenesis was investigated. Finasteride decrease melanin level in melanocyte melan-a cells and B16F10 melanoma cells without inducing cytotoxicity. MC1R (melanocortin 1 receptor) protein expression was also inhibited by finasteride thereby decreasing the expression of adenylate cyclase, MITF (Melanogenesis associated transcription factor), tyrosinases, TRP (tyrosinase-related protein) -1 and -2. Thus our study suggest that finasteride inhibits melanogenesis in melanocyte and melanoma cells by inhibiting MC1R.Finasteride is a well-known 5α-reductase inhibitor used for treatment of alopecia and prostate cancer. But the effect of finasteride in regulating melanogenesis is still unclear. In the present study the role of finasteride on melanogenesis was investigated. Finasteride decrease melanin level in melanocyte melan-a cells and B16F10 melanoma cells without inducing cytotoxicity. MC1R (melanocortin 1 receptor) protein expression was also inhibited by finasteride thereby decreasing the expression of adenylate cyclase, MITF (Melanogenesis associated transcription factor), tyrosinases, TRP (tyrosinase-related protein) -1 and -2. Thus our study suggest that finasteride inhibits melanogenesis in melanocyte and melanoma cells by inhibiting MC1R. |
Author | Kim, Sun Yeou Yumnam, Silvia Seo, Jae Ok Jeong, Kwang Won |
Author_xml | – sequence: 1 givenname: Jae Ok surname: Seo fullname: Seo, Jae Ok organization: College of Pharmacy, Gachon University – sequence: 2 givenname: Silvia surname: Yumnam fullname: Yumnam, Silvia organization: College of Pharmacy, Gachon University – sequence: 3 givenname: Kwang Won surname: Jeong fullname: Jeong, Kwang Won organization: College of Pharmacy, Gachon University, Gachon Institute of Pharmaceutical Science, Gachon University – sequence: 4 givenname: Sun Yeou orcidid: 0000-0001-8044-5613 surname: Kim fullname: Kim, Sun Yeou email: sunnykim@gachon.ac.kr organization: College of Pharmacy, Gachon University, Gachon Medical Research Institute, Gil Medical Center, Gachon Institute of Pharmaceutical Science, Gachon University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29397551$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002325701$$DAccess content in National Research Foundation of Korea (NRF) |
BookMark | eNqNUU1v1DAQtVAR3RZ-ABeUIxwC_ojj-IJUVRQqVUJC5WxNnMmu26y92Al0_z1Os3weCqfR2O-9efPmhBz54JGQ54y-ZpSqN4lxrnhJWVPmnpd3j8iKaVWXQjX1EVlRLkVZ81ofk5OUbigVtZTyCTnmWmglJVuR3YXzkEaMrsPC-Y1r3ZiKLQ7gwxo9JpeKcRPDtN4UEdfTAKMLvgh9fsUCOvT7_ISF3dsB0ixxINv9iKkA3x36LRQWhyE9JY97GBI-O9RT8vni3fX5h_Lq4_vL87Or0kqqxxKzu1a3VSt6UJ1qpGbWikrYFpq-B9l3oKHqbaUU1B2ljMueMaCorVbUCnFKXi26Pvbm1joTwN3XdTC30Zx9ur40XDMuZJOxfMFOfgf7bzAMZhfdFuLeMGrmqM0StclRzz03d5n0diHtpnaLnUU_RvhFnMf9-ePdJg__amRehgqdBV4eBGL4MmEazdalOSPwGKZkOK1kwysmq39CmdaVqOtaqgx98butn35-nDwD1AKwMaQUsTfWjfdXzS7d8ODG7C_m_6R0iDZlrF9jNDdhij5f_gHSd4jh4t8 |
CitedBy_id | crossref_primary_10_1016_j_ultrasmedbio_2023_01_017 crossref_primary_10_3390_molecules23051145 crossref_primary_10_3390_plants10081653 crossref_primary_10_2147_IJN_S296793 crossref_primary_10_1002_ijc_33555 crossref_primary_10_1016_j_bbrc_2018_10_125 crossref_primary_10_1039_D4OB01225A crossref_primary_10_1111_exd_14569 crossref_primary_10_1186_s13065_023_01082_2 crossref_primary_10_1016_j_ultrasmedbio_2020_05_003 crossref_primary_10_3390_molecules30020289 crossref_primary_10_1002_ptr_6832 crossref_primary_10_1186_s12906_021_03492_y crossref_primary_10_3390_antiox13101248 |
Cites_doi | 10.1038/sj.jid.5700840 10.3109/09546634.2013.813011 10.1016/j.pharep.2014.02.022 10.1211/jpp.61.12.0011 10.1016/j.molcel.2013.08.010 10.1111/j.1527-3458.2006.00053.x 10.1046/j.0022-202x.2001.01421.x 10.1002/jcb.240501225 10.1152/physrev.00044.2003 10.3390/molecules19032808 10.1083/jcb.97.2.480 10.1016/j.theriogenology.2015.09.036 10.1016/0960-0760(94)90295-X 10.1002/ijc.29050 10.1038/nature05660 10.1158/1541-7786.MCR-11-0436 10.1038/nature11624 10.4161/derm.3.4.17454 10.1111/j.1755-148X.2011.00898.x 10.1001/jamafacial.2014.316 10.1038/jid.1959.155 10.1111/j.1751-1097.2011.00970.x 10.1056/NEJM199210223271701 10.4062/biomolther.2013.081 10.1038/bjc.2013.385 10.1073/pnas.1201917110 10.1016/0092-8674(93)90572-8 10.1016/0022-202X(89)90177-2 10.1111/1523-1747.ep12324390 10.1111/j.1464-410X.2009.08743.x 10.1002/ptr.3417 10.1038/nm.3194 10.1126/science.1325670 10.1111/php.12335 10.1111/j.1600-0749.2005.00278.x 10.1002/j.1460-2075.1992.tb05082.x |
ContentType | Journal Article |
Copyright | The Author(s) 2018 |
Copyright_xml | – notice: The Author(s) 2018 |
DBID | C6C AAYXX CITATION NPM 7X8 7S9 L.6 5PM ADTOC UNPAY ACYCR |
DOI | 10.1007/s12272-018-1002-x |
DatabaseName | Springer Nature OA Free Journals CrossRef PubMed MEDLINE - Academic AGRICOLA AGRICOLA - Academic PubMed Central (Full Participant titles) Unpaywall for CDI: Periodical Content Unpaywall Korean Citation Index |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
DatabaseTitleList | AGRICOLA PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1976-3786 |
EndPage | 332 |
ExternalDocumentID | oai_kci_go_kr_ARTI_2912358 10.1007/s12272-018-1002-x PMC5859039 29397551 10_1007_s12272_018_1002_x |
Genre | Journal Article |
GrantInformation_xml | – fundername: R&D Program for Forest Science Technology grantid: 2017036A00-1719-BA01 – fundername: ; grantid: 2017036A00-1719-BA01 |
GroupedDBID | --- -53 -56 -5G -BR -EM -Y2 -~C .86 .UV .VR 06C 06D 0R~ 0VY 1N0 2.D 203 23N 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2VQ 2WC 2~H 30V 3SX 4.4 406 408 40D 40E 53G 5GY 5VS 67N 67Z 6J9 6NX 8TC 8UJ 95- 95. 95~ 96X 9ZL AAAVM AABHQ AACDK AAHBH AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABDZT ABECU ABFTV ABHQN ABJNI ABJOX ABKCH ABMNI ABMQK ABNWP ABPLI ABQBU ABQSL ABSXP ABTEG ABTKH ABTMW ABWNU ABXPI ACAOD ACBXY ACDTI ACGFO ACGFS ACHSB ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACREN ACSNA ACUDM ACZOJ ADHHG ADHIR ADINQ ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADYOE ADZKW AEBTG AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFGCZ AFLOW AFQWF AFWTZ AFYQB AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHKAY AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMTXH AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BBWZM BDATZ BGNMA C1A C6C CAG COF CS3 CSCUP DDRTE DNIVK DPUIP EBLON EBS EIOEI EJD EMOBN ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GRRUI H13 HF~ HG6 HMJXF HRMNR HVGLF HZ~ IJ- IKXTQ IWAJR IXC IXD I~X I~Z J-C J0Z JBSCW JZLTJ KOV KPH KVFHK LLZTM M4Y MA- MZR N2Q N9A NDZJH NF0 NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OVD P19 P2P PF0 PT4 PT5 QOK QOR QOS R89 R9I RHV RNI RNS ROL RPX RSV RZK S16 S1Z S26 S27 S28 S3A S3B SAP SBL SCLPG SDE SDH SHX SISQX SJN SJYHP SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SZ9 SZN T13 T16 TEORI TSG TSK TUC U2A U9L UG4 UOJIU UTJUX UZXMN VC2 VFIZW W48 WK6 WK8 YLTOR Z45 Z7U Z7V Z7W Z83 Z87 Z8O Z8P Z8Q Z91 ZMTXR ZOVNA ZZE ~A9 AAPKM AAYXX ABBRH ABDBE ABFSG ABRTQ ACSTC ADHKG AEZWR AFDZB AFHIU AFOHR AGQPQ AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION NPM 7X8 7S9 L.6 5PM ADTOC UNPAY AABYN AAFGU AAKSU AAPBV AAYFA ABFGW ABKAS ACBMV ACBRV ACBYP ACIGE ACIPQ ACTTH ACVWB ACWMK ACYCR ADMDM ADOXG AEEQQ AEFTE AESTI AEVTX AFAFS AFNRJ AGGBP AGKHE AIMYW AJDOV AKQUC UNUBA Z7X |
ID | FETCH-LOGICAL-c509t-e551b9b4b3fa7d78591cc343cba8ffa5fda9a4fc477a6d00125f11a0e9c970c33 |
IEDL.DBID | C6C |
ISSN | 0253-6269 1976-3786 |
IngestDate | Tue Nov 21 21:13:48 EST 2023 Wed Oct 01 16:04:38 EDT 2025 Thu Aug 21 14:06:46 EDT 2025 Fri Sep 05 05:37:35 EDT 2025 Thu Sep 04 23:04:20 EDT 2025 Thu Apr 03 07:01:56 EDT 2025 Wed Oct 01 04:24:55 EDT 2025 Thu Apr 24 23:08:02 EDT 2025 Fri Feb 21 02:37:00 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | Finasteride MC1R Melanogenesis B16F10 Melan-a |
Language | English |
License | Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. cc-by |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c509t-e551b9b4b3fa7d78591cc343cba8ffa5fda9a4fc477a6d00125f11a0e9c970c33 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0001-8044-5613 |
OpenAccessLink | https://doi.org/10.1007/s12272-018-1002-x |
PMID | 29397551 |
PQID | 1994366657 |
PQPubID | 23479 |
PageCount | 9 |
ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_2912358 unpaywall_primary_10_1007_s12272_018_1002_x pubmedcentral_primary_oai_pubmedcentral_nih_gov_5859039 proquest_miscellaneous_2045824154 proquest_miscellaneous_1994366657 pubmed_primary_29397551 crossref_citationtrail_10_1007_s12272_018_1002_x crossref_primary_10_1007_s12272_018_1002_x springer_journals_10_1007_s12272_018_1002_x |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2018-03-01 |
PublicationDateYYYYMMDD | 2018-03-01 |
PublicationDate_xml | – month: 03 year: 2018 text: 2018-03-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Seoul |
PublicationPlace_xml | – name: Seoul – name: Korea (South) |
PublicationTitle | Archives of pharmacal research |
PublicationTitleAbbrev | Arch. Pharm. Res |
PublicationTitleAlternate | Arch Pharm Res |
PublicationYear | 2018 |
Publisher | Pharmaceutical Society of Korea 대한약학회 |
Publisher_xml | – name: Pharmaceutical Society of Korea – name: 대한약학회 |
References | Rousso, Kim (CR28) 2014; 16 Robbins, Nadeau, Johnson, Kelly, Roselli-Rehfuss, Baack, Mountjoy, Cone (CR27) 1993; 72 Newton, Cook, Roberts, Leonard, Sturm (CR25) 2007; 127 Yang, Son, Lee, Jeon, Lee (CR36) 2011; 25 Dessinioti, Antoniou, Katsambas, Stratigos (CR7) 2011; 87 Mountjoy, Robbins, Mortrud, Cone (CR23) 1992; 257 Choi, Lee, Kim, Ju, Baek, Park, Lee (CR5) 2014; 19 Stanisz, Seifert, Tilgen, Vogt, Rass (CR31) 2011; 3 Tsukamoto, Jackson, Urabe, Montague, Hearing (CR32) 1992; 11 Lee, Seo, Baek, Kim (CR18) 2014; 22 Halaban, Pomerantz, Marshall, Lambert, Lerner (CR14) 1983; 97 Chen, Puy, Simard, Li, Singh, Labrie (CR4) 1995; 105 Cao, Wan, Hacker, Dai, Lenna, Jimenez-Cervantes, Wang, Leslie, Xu, Widlund, Ryu, Alani, Dutton-Regester, Goding, Hayward, Wei, Cui (CR3) 2013; 51 Ramli, Giribabu, Muniandy, Salleh (CR26) 2016; 85 Hosoi, Abe, Suda, Kuroki (CR15) 1985; 45 Vis, Schroder (CR33) 2009; 104 Gormley, Stoner, Bruskewitz, Imperato-Mcginley, Walsh, Mcconnell, Andriole, Geller, Bracken, Tenover, Vaughan (CR11) 1992; 327 Nasti, Timares (CR24) 2014 Bischitz, Snell (CR1) 1959; 33 Weinstein, Virtamo, Albanes (CR34) 2013; 109 Wolnicka-Glubisz, Strickland, Wielgus, Anver, Merlino, De Fabo, Noonan (CR35) 2014; 136 Garcia-Borron, Sanchez-Laorden, Jimenez-Cervantes (CR9) 2005; 18 Gupta, Charrette (CR12) 2014; 25 Kennedy, Ter Huurne, Berkhout, Gruis, Bastiaens, Bergman, Willemze, Bavinck (CR17) 2001; 117 Mitra, Luo, Morgan, Wang, Hoang, Lo, Guerrero, Lennerz, Mihm, Wargo, Robinson, Devi, Vanover, D’orazio, Mcmahon, Bosenberg, Haigis, Haber, Wang, Fisher (CR22) 2012; 491 Geller, Sionit (CR10) 1992; Suppl 16h Bolognia, Murray, Pawelek (CR2) 1989; 92 Ha, Koketsu, Lee, Moon, Kim, Yoon, Kim (CR13) 2009; 61 Kadekaro, Chen, Yang, Chen, Jameson, Swope, Cheng, Kadakia, Abdel-Malek (CR16) 2012; 10 Slominski, Tobin, Shibahara, Wortsman (CR29) 2004; 84 Lyons, Bastian, Mccormick (CR20) 2013; 110 Zabkowski (CR37) 2014; 66 Chou, Takeo, Rabbani, Hu, Lee, Chung, Carucci, Overbeek, Ito (CR6) 2013; 19 Finn, Beadles-Bohling, Beckley, Ford, Gililland, Gorin-Meyer, Wiren (CR8) 2006; 12 Lin, Fisher (CR19) 2007; 445 Mcleod, Ranson, Mason (CR21) 1994; 49 Slominski, Zmijewski, Pawelek (CR30) 2012; 25 J Lyons (1002_CR20) 2013; 110 J Cao (1002_CR3) 2013; 51 SK Ha (1002_CR13) 2009; 61 A Slominski (1002_CR29) 2004; 84 T Zabkowski (1002_CR37) 2014; 66 TH Nasti (1002_CR24) 2014 J Hosoi (1002_CR15) 1985; 45 WC Chou (1002_CR6) 2013; 19 K Tsukamoto (1002_CR32) 1992; 11 JC Garcia-Borron (1002_CR9) 2005; 18 LS Robbins (1002_CR27) 1993; 72 JY Lin (1002_CR19) 2007; 445 SD Mcleod (1002_CR21) 1994; 49 R Halaban (1002_CR14) 1983; 97 H Stanisz (1002_CR31) 2011; 3 AN Vis (1002_CR33) 2009; 104 KG Mountjoy (1002_CR23) 1992; 257 A Slominski (1002_CR30) 2012; 25 AK Gupta (1002_CR12) 2014; 25 D Mitra (1002_CR22) 2012; 491 A Wolnicka-Glubisz (1002_CR35) 2014; 136 PG Bischitz (1002_CR1) 1959; 33 C Chen (1002_CR4) 1995; 105 AL Kadekaro (1002_CR16) 2012; 10 RA Newton (1002_CR25) 2007; 127 SJ Weinstein (1002_CR34) 2013; 109 C Dessinioti (1002_CR7) 2011; 87 C Kennedy (1002_CR17) 2001; 117 SY Choi (1002_CR5) 2014; 19 TH Lee (1002_CR18) 2014; 22 J Geller (1002_CR10) 1992; Suppl 16h DE Rousso (1002_CR28) 2014; 16 DA Finn (1002_CR8) 2006; 12 J Bolognia (1002_CR2) 1989; 92 YM Yang (1002_CR36) 2011; 25 GJ Gormley (1002_CR11) 1992; 327 NS Ramli (1002_CR26) 2016; 85 |
References_xml | – volume: 127 start-page: 2216 year: 2007 end-page: 2227 ident: CR25 article-title: Post-transcriptional regulation of melanin biosynthetic enzymes by cAMP and resveratrol in human melanocytes publication-title: J Invest Dermatol doi: 10.1038/sj.jid.5700840 – volume: 25 start-page: 156 year: 2014 end-page: 161 ident: CR12 article-title: The efficacy and safety of 5alpha-reductase inhibitors in androgenetic alopecia: a network meta-analysis and benefit-risk assessment of finasteride and dutasteride publication-title: J Dermatolog Treat doi: 10.3109/09546634.2013.813011 – volume: 66 start-page: 565 year: 2014 end-page: 569 ident: CR37 article-title: Evaluation of the clinical indications, adverse drug reactions, and finasteride use in patients with benign prostatic hyperplasia in Poland publication-title: Pharmacol Rep doi: 10.1016/j.pharep.2014.02.022 – volume: 61 start-page: 1657 year: 2009 end-page: 1663 ident: CR13 article-title: Inhibitory effects of 1,3-thiazine derivatives on melanogenesis publication-title: J Pharm Pharmacol doi: 10.1211/jpp.61.12.0011 – volume: 11 start-page: 519 year: 1992 end-page: 526 ident: CR32 article-title: A second tyrosinase-related protein, TRP-2, is a melanogenic enzyme termed DOPAchrome tautomerase publication-title: EMBO J – year: 2014 ident: CR24 article-title: MC1R, Eumelanin and Pheomelanin: their role in determining the susceptibility to skin cancer publication-title: Photochem Photobiol – volume: 18 start-page: 393 year: 2005 end-page: 410 ident: CR9 article-title: Melanocortin-1 receptor structure and functional regulation publication-title: Pigment Cell Res – volume: 51 start-page: 409 year: 2013 end-page: 422 ident: CR3 article-title: MC1R is a potent regulator of PTEN after UV exposure in melanocytes publication-title: Mol Cell doi: 10.1016/j.molcel.2013.08.010 – volume: 12 start-page: 53 year: 2006 end-page: 76 ident: CR8 article-title: A new look at the 5alpha-reductase inhibitor finasteride publication-title: CNS Drug Rev doi: 10.1111/j.1527-3458.2006.00053.x – volume: 117 start-page: 294 year: 2001 end-page: 300 ident: CR17 article-title: Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color publication-title: J Invest Dermatol doi: 10.1046/j.0022-202x.2001.01421.x – volume: Suppl 16h start-page: 109 year: 1992 end-page: 112 ident: CR10 article-title: Castration-like effects on the human prostate of a 5 alpha-reductase inhibitor, finasteride publication-title: J Cell Biochem doi: 10.1002/jcb.240501225 – volume: 84 start-page: 1155 year: 2004 end-page: 1228 ident: CR29 article-title: Melanin pigmentation in mammalian skin and its hormonal regulation publication-title: Physiol Rev doi: 10.1152/physrev.00044.2003 – volume: 19 start-page: 2808 year: 2014 end-page: 2818 ident: CR5 article-title: Inhibitory effect of corn silk on skin pigmentation publication-title: Molecules doi: 10.3390/molecules19032808 – volume: 97 start-page: 480 year: 1983 end-page: 488 ident: CR14 article-title: Regulation of tyrosinase in human melanocytes grown in culture publication-title: J Cell Biol doi: 10.1083/jcb.97.2.480 – volume: 85 start-page: 238 year: 2016 end-page: 246 ident: CR26 article-title: Testosterone regulates levels of cystic fibrosis transmembrane regulator, adenylate cyclase, and cAMP in the seminal vesicles of orchidectomized rats publication-title: Theriogenology doi: 10.1016/j.theriogenology.2015.09.036 – volume: 49 start-page: 9 year: 1994 end-page: 14 ident: CR21 article-title: Effects of estrogens on human melanocytes in vitro publication-title: J Steroid Biochem Mol Biol doi: 10.1016/0960-0760(94)90295-X – volume: 136 start-page: 752 issue: 4 year: 2014 end-page: 760 ident: CR35 article-title: A melanin-independent interaction between Mc1r and Met signaling pathways is required for HGF-dependent melanoma publication-title: Int J Cancer doi: 10.1002/ijc.29050 – volume: 445 start-page: 843 year: 2007 end-page: 850 ident: CR19 article-title: Melanocyte biology and skin pigmentation publication-title: Nature doi: 10.1038/nature05660 – volume: 10 start-page: 778 year: 2012 end-page: 786 ident: CR16 article-title: Alpha-melanocyte-stimulating hormone suppresses oxidative stress through a p53-mediated signaling pathway in human melanocytes publication-title: Mol Cancer Res doi: 10.1158/1541-7786.MCR-11-0436 – volume: 491 start-page: 449 year: 2012 end-page: 453 ident: CR22 article-title: An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair/fair skin background publication-title: Nature doi: 10.1038/nature11624 – volume: 3 start-page: 259 year: 2011 end-page: 265 ident: CR31 article-title: Reciprocal responses of fibroblasts and melanocytes to alpha-MSH depending on MC1R polymorphisms publication-title: Dermatoendocrinol doi: 10.4161/derm.3.4.17454 – volume: 25 start-page: 14 year: 2012 end-page: 27 ident: CR30 article-title: L-tyrosine and -DOPA as hormone-like regulators of melanocytes functions publication-title: Pigment Cell Melanoma Res doi: 10.1111/j.1755-148X.2011.00898.x – volume: 16 start-page: 444 issue: 6 year: 2014 end-page: 450 ident: CR28 article-title: A review of medical and surgical treatment options for androgenetic alopecia publication-title: JAMA Facial Plast Surg doi: 10.1001/jamafacial.2014.316 – volume: 45 start-page: 1474 year: 1985 end-page: 1478 ident: CR15 article-title: Regulation of melanin synthesis of B16 mouse melanoma cells by 1 alpha, 25-dihydroxyvitamin D3 and retinoic acid publication-title: Cancer Res – volume: 33 start-page: 299 year: 1959 end-page: 306 ident: CR1 article-title: The effect of testosterone on the melanocytes and melanin in the skin of the intact and orchidectomised male guinea-pig publication-title: J Invest Dermatol doi: 10.1038/jid.1959.155 – volume: 87 start-page: 978 year: 2011 end-page: 987 ident: CR7 article-title: Melanocortin 1 receptor variants: functional role and pigmentary associations publication-title: Photochem Photobiol doi: 10.1111/j.1751-1097.2011.00970.x – volume: 327 start-page: 1185 year: 1992 end-page: 1191 ident: CR11 article-title: The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group publication-title: N Engl J Med doi: 10.1056/NEJM199210223271701 – volume: 22 start-page: 35 year: 2014 end-page: 40 ident: CR18 article-title: Inhibitory effects of resveratrol on melanin synthesis in ultraviolet B-induced pigmentation in Guinea pig skin publication-title: Biomol Ther (Seoul) doi: 10.4062/biomolther.2013.081 – volume: 109 start-page: 747 year: 2013 end-page: 750 ident: CR34 article-title: Pigmentation-related phenotypes and risk of prostate cancer publication-title: Br J Cancer doi: 10.1038/bjc.2013.385 – volume: 110 start-page: 13845 year: 2013 end-page: 13850 ident: CR20 article-title: MC1R and cAMP signaling inhibit cdc25B activity and delay cell cycle progression in melanoma cells publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.1201917110 – volume: 72 start-page: 827 year: 1993 end-page: 834 ident: CR27 article-title: Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function publication-title: Cell doi: 10.1016/0092-8674(93)90572-8 – volume: 92 start-page: 651 year: 1989 end-page: 656 ident: CR2 article-title: UVB-induced melanogenesis may be mediated through the MSH-receptor system publication-title: J Invest Dermatol doi: 10.1016/0022-202X(89)90177-2 – volume: 105 start-page: 678 year: 1995 end-page: 682 ident: CR4 article-title: Local and systemic reduction by topical finasteride or flutamide of hamster flank organ size and enzyme activity publication-title: J Invest Dermatol doi: 10.1111/1523-1747.ep12324390 – volume: 104 start-page: 1191 year: 2009 end-page: 1197 ident: CR33 article-title: Key targets of hormonal treatment of prostate cancer. Part 2: the androgen receptor and 5alpha-reductase publication-title: BJU Int doi: 10.1111/j.1464-410X.2009.08743.x – volume: 25 start-page: 1166 year: 2011 end-page: 1173 ident: CR36 article-title: Quercetin inhibits alpha-MSH-stimulated melanogenesis in B16F10 melanoma cells publication-title: Phytother Res doi: 10.1002/ptr.3417 – volume: 19 start-page: 924 year: 2013 end-page: 929 ident: CR6 article-title: Direct migration of follicular melanocyte stem cells to the epidermis after wounding or UVB irradiation is dependent on Mc1r signaling publication-title: Nat Med doi: 10.1038/nm.3194 – volume: 257 start-page: 1248 year: 1992 end-page: 1251 ident: CR23 article-title: The cloning of a family of genes that encode the melanocortin receptors publication-title: Science doi: 10.1126/science.1325670 – volume: 16 start-page: 444 issue: 6 year: 2014 ident: 1002_CR28 publication-title: JAMA Facial Plast Surg doi: 10.1001/jamafacial.2014.316 – year: 2014 ident: 1002_CR24 publication-title: Photochem Photobiol doi: 10.1111/php.12335 – volume: 10 start-page: 778 year: 2012 ident: 1002_CR16 publication-title: Mol Cancer Res doi: 10.1158/1541-7786.MCR-11-0436 – volume: 3 start-page: 259 year: 2011 ident: 1002_CR31 publication-title: Dermatoendocrinol doi: 10.4161/derm.3.4.17454 – volume: 127 start-page: 2216 year: 2007 ident: 1002_CR25 publication-title: J Invest Dermatol doi: 10.1038/sj.jid.5700840 – volume: 51 start-page: 409 year: 2013 ident: 1002_CR3 publication-title: Mol Cell doi: 10.1016/j.molcel.2013.08.010 – volume: 136 start-page: 752 issue: 4 year: 2014 ident: 1002_CR35 publication-title: Int J Cancer doi: 10.1002/ijc.29050 – volume: 61 start-page: 1657 year: 2009 ident: 1002_CR13 publication-title: J Pharm Pharmacol doi: 10.1211/jpp.61.12.0011 – volume: 22 start-page: 35 year: 2014 ident: 1002_CR18 publication-title: Biomol Ther (Seoul) doi: 10.4062/biomolther.2013.081 – volume: 66 start-page: 565 year: 2014 ident: 1002_CR37 publication-title: Pharmacol Rep doi: 10.1016/j.pharep.2014.02.022 – volume: 18 start-page: 393 year: 2005 ident: 1002_CR9 publication-title: Pigment Cell Res doi: 10.1111/j.1600-0749.2005.00278.x – volume: 445 start-page: 843 year: 2007 ident: 1002_CR19 publication-title: Nature doi: 10.1038/nature05660 – volume: 19 start-page: 924 year: 2013 ident: 1002_CR6 publication-title: Nat Med doi: 10.1038/nm.3194 – volume: 12 start-page: 53 year: 2006 ident: 1002_CR8 publication-title: CNS Drug Rev doi: 10.1111/j.1527-3458.2006.00053.x – volume: 45 start-page: 1474 year: 1985 ident: 1002_CR15 publication-title: Cancer Res – volume: 85 start-page: 238 year: 2016 ident: 1002_CR26 publication-title: Theriogenology doi: 10.1016/j.theriogenology.2015.09.036 – volume: 491 start-page: 449 year: 2012 ident: 1002_CR22 publication-title: Nature doi: 10.1038/nature11624 – volume: 72 start-page: 827 year: 1993 ident: 1002_CR27 publication-title: Cell doi: 10.1016/0092-8674(93)90572-8 – volume: 19 start-page: 2808 year: 2014 ident: 1002_CR5 publication-title: Molecules doi: 10.3390/molecules19032808 – volume: 117 start-page: 294 year: 2001 ident: 1002_CR17 publication-title: J Invest Dermatol doi: 10.1046/j.0022-202x.2001.01421.x – volume: 25 start-page: 156 year: 2014 ident: 1002_CR12 publication-title: J Dermatolog Treat doi: 10.3109/09546634.2013.813011 – volume: 110 start-page: 13845 year: 2013 ident: 1002_CR20 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.1201917110 – volume: 84 start-page: 1155 year: 2004 ident: 1002_CR29 publication-title: Physiol Rev doi: 10.1152/physrev.00044.2003 – volume: 25 start-page: 1166 year: 2011 ident: 1002_CR36 publication-title: Phytother Res doi: 10.1002/ptr.3417 – volume: 11 start-page: 519 year: 1992 ident: 1002_CR32 publication-title: EMBO J doi: 10.1002/j.1460-2075.1992.tb05082.x – volume: 109 start-page: 747 year: 2013 ident: 1002_CR34 publication-title: Br J Cancer doi: 10.1038/bjc.2013.385 – volume: 92 start-page: 651 year: 1989 ident: 1002_CR2 publication-title: J Invest Dermatol doi: 10.1016/0022-202X(89)90177-2 – volume: 105 start-page: 678 year: 1995 ident: 1002_CR4 publication-title: J Invest Dermatol doi: 10.1111/1523-1747.ep12324390 – volume: 97 start-page: 480 year: 1983 ident: 1002_CR14 publication-title: J Cell Biol doi: 10.1083/jcb.97.2.480 – volume: 49 start-page: 9 year: 1994 ident: 1002_CR21 publication-title: J Steroid Biochem Mol Biol doi: 10.1016/0960-0760(94)90295-X – volume: 87 start-page: 978 year: 2011 ident: 1002_CR7 publication-title: Photochem Photobiol doi: 10.1111/j.1751-1097.2011.00970.x – volume: 104 start-page: 1191 year: 2009 ident: 1002_CR33 publication-title: BJU Int doi: 10.1111/j.1464-410X.2009.08743.x – volume: 25 start-page: 14 year: 2012 ident: 1002_CR30 publication-title: Pigment Cell Melanoma Res doi: 10.1111/j.1755-148X.2011.00898.x – volume: 257 start-page: 1248 year: 1992 ident: 1002_CR23 publication-title: Science doi: 10.1126/science.1325670 – volume: Suppl 16h start-page: 109 year: 1992 ident: 1002_CR10 publication-title: J Cell Biochem doi: 10.1002/jcb.240501225 – volume: 33 start-page: 299 year: 1959 ident: 1002_CR1 publication-title: J Invest Dermatol doi: 10.1038/jid.1959.155 – volume: 327 start-page: 1185 year: 1992 ident: 1002_CR11 publication-title: N Engl J Med doi: 10.1056/NEJM199210223271701 |
SSID | ssj0036555 |
Score | 2.2735136 |
Snippet | Finasteride is a well-known 5α-reductase inhibitor used for treatment of alopecia and prostate cancer. But the effect of finasteride in regulating... Finasteride is a well-known 5a-reductase inhibitorused for treatment of alopecia and prostate cancer. But theeffect of finasteride in regulating melanogenesis... |
SourceID | nrf unpaywall pubmedcentral proquest pubmed crossref springer |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 324 |
SubjectTerms | adenylate cyclase alopecia alpha-melanocyte-stimulating hormone cytotoxicity enzyme inhibitors Medicine melanin melanocytes melanogenesis melanoma Pharmacology/Toxicology Pharmacy prostatic neoplasms protein synthesis Research Article transcription factors 약학 |
SummonAdditionalLinks | – databaseName: Unpaywall dbid: UNPAY link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELba7QE48C6ElwxCPdBmyebhJMcKtSpIVHvoSuVkOY69jXbrrDZZ0fDrmclruwWKEKfIsRMlkxn7c2bmG0LeewoWBhYAcpORtn0ApTagBN9W2gkVE5JJhvnOX0_ZycT_ch6cb5GjLhemjnbvXJJNTgOyNJny4yLV17z6xch1QwwqQHJSMOqrIfRvkx2GfqYB2Zmcjg-_1f9XAs8G0B7X3uWQgUFFrPNu1il0N-6zsT5tm6X-HfT8NYKyd6PeI3dWZiGq72I-v7ZSHT9oIkqKmuAQA1Rmw1WZDOWPG_SP_y2Eh-R-i2XpYaN8j8iWMo_J3rghw64O6Nk6t6s4oHt0vKbJrp6QBZYGRpqGLFU0MxdZkpUFvVRzYfIpzsBZQdsqQnSppm2ZMZprOKuogPmyglOKykrCDgBv0V4sK4DPVJi0bV8Kiu6J4imZHB-dfTqx2_oPtgQYU9oK0FwSJ37iaRGmITLtSen5nkxEpLUIdCpi4Wvph6FgKQK3QI9GwlGxjENHet4uGZjcqOeEJsIP1IixhGnYcAEs0pGKmUK-Q-H4qW8Rp_vqXLbk6FijY87XtM4oaw6yxrbLryzyob9k0TCD3Db4HagSn8mMI583Hqc5ny057Fo-czeuM5Yt8rbTNA5GjqIRRuWrgiOBs8fQSfbnMVhXIEI8Bi_zrNHO_rkA08UhSNMi4Ybe9gPwoTZ7THZRk43DdjJ2vNgi-51C8naWK2573f3eCP4unBf_NPolueuixtdxgK_IoFyu1GsAhmXypjX7n1VzXHc priority: 102 providerName: Unpaywall |
Title | Finasteride inhibits melanogenesis through regulation of the adenylate cyclase in melanocytes and melanoma cells |
URI | https://link.springer.com/article/10.1007/s12272-018-1002-x https://www.ncbi.nlm.nih.gov/pubmed/29397551 https://www.proquest.com/docview/1994366657 https://www.proquest.com/docview/2045824154 https://pubmed.ncbi.nlm.nih.gov/PMC5859039 https://link.springer.com/content/pdf/10.1007%2Fs12272-018-1002-x.pdf https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002325701 |
UnpaywallVersion | publishedVersion |
Volume | 41 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Archives of Pharmacal Research, 2018, 41(3), , pp.324-332 |
journalDatabaseRights | – providerCode: PRVLSH databaseName: SpringerLink Journals customDbUrl: mediaType: online eissn: 1976-3786 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0036555 issn: 1976-3786 databaseCode: AFBBN dateStart: 19970201 isFulltext: true providerName: Library Specific Holdings – providerCode: PRVAVX databaseName: SpringerLINK - Czech Republic Consortium customDbUrl: eissn: 1976-3786 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0036555 issn: 1976-3786 databaseCode: AGYKE dateStart: 19970101 isFulltext: true titleUrlDefault: http://link.springer.com providerName: Springer Nature – providerCode: PRVAVX databaseName: SpringerLink Journals (ICM) customDbUrl: eissn: 1976-3786 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0036555 issn: 1976-3786 databaseCode: U2A dateStart: 19970101 isFulltext: true titleUrlDefault: http://www.springerlink.com/journals/ providerName: Springer Nature |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bb9MwFLZgk7g8IBi3cJkMQntgi0gTx6kfu2plgFb1YZW2J8tx7C1al1RNK8i_55zcSmEM8ZLIjm05PsfHn3Xs7xDyITCwMPAQkJvuW5cBKHUBJTDXWC8yXGmuOd53Phnz4yn7ehaeNWTReBfmN__9p6Ln-xEeHkASUpi8ABe3Q7C7eHpvyIet0Q14WAU4hRU8cAGji9aBeVMTG0vQ3Wxhb0KXfx6S7DylD8n9VTZX5Xc1m_2yGI0ek0cNiqSDWuxPyB2T7ZB7J42ffIfsTWpG6vKAnq4vWBUHdI9O1lzV5VMyx_i8yJWQJoam2WUap8uCXpuZyvILNINpQZtQPnRRh60HQdLcQq6hCoxWCVmG6lIDDMcmmsq6BAxLVZY06WtF0UdQPCPT0dHp8NhtgjC4GrDE0jUAqWIRsziwKkoipLvTOmCBjlXfWhXaRAnFrGZRpHiC6Cm0vZ7yjNAi8nQQPCdbWZ6Zl4TGioWmx3nMLex6AJvYvhHcIOmg8ljCHOK1cpG6YSjHQBkzueZWRlFKECWmffnDIR-7KvOanuO2wu9B2PJKpxJJtfF9kcurhYStwxfpi-rasEPetbogYabh0KjM5KtCIotywNFT9fcySO7fR1AEP_Oi1p-uXwCsRASj6ZBoQ7O6AtipzS9ZelkxfsOeTniBcMh-q4OyMTXFbb-736npvwfn1X-1_Zo88HFCVYfx3pCt5WJl3gI6W8a7ZHswOjwc4_vz-bej3WqewnPqDyBvOp4Mzn8CysE34Q |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9MwED9BJzF44GN8lU-D0B62ZUobx0keJ7SxsXXaQyeNJ8tx7C5ql1ZNKwh_PXet01IYQ3uKkjiWfTmff9bd_Q7gU2BwYxAhIjcdW48jKPUQJXDPWD8yQmmhBeU7d07F4Tn_ehFeuDzuso52r12SM0u9THZrtyMKIyA6UlzGCBzXeCuOeQPW9r58O96vDXAgwlmxU9zNAw_xelI7M6_rZGU7uluM7XVI8--AyYXX9AGsT4uRqr6rweC3jengEXTrKc3jUfq700m6q3_-wfZ4yzk_hocOqLK9uWY9gTum2IB7HeeK34DNsznpdbXDusscrnKHbbKzJR129RRGVAKY6BjyzLC8uMzTfFKyKzNQxbBHljYvmasWxMam58qJsaHFp4YptIsVPjJMVxqRPnXhPtYVwmSmiszdXylGbojyGZwf7Hc_H3quzoOnEa5MPIOoLU1SngZWRVlEjHpaBzzQqYqtVaHNVKK41TyKlMgIoIW21VK-SXQS-ToInkOjGBbmJbBU8dC0hEiFxYMVwh8bm0QY4jVUPs94E_z6d0vtSNCpFsdALumbSeQSRU73bfmjCVuLT0ZzBpCbGn9EHZJ9nUvi7aZrbyj7Y4mnkyPZTmaZyU34UKuYxMVMolGFGU5LSUTNgSBn2L_bUP2AmHAXTubFXC0X40LslkQozSZEKwq7aECDWn1T5JczUnE8NiZ-kDRhu9ZE6axZedN0txfa_3_hvLpV3-9h_bDbOZEnR6fHr-F-mxbBLPbvDTQm46l5i2Bwkr5zi_8XYHxWSg |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELagSIUeEJRXeBqEeqCNmk0cZ32sgFULtNpDV-rNchy7jbp1VpusSv49M3nssqIUcYri2JbjGXs-azzfEPIxMmAYeAzITQ-tzwCU-oASmG9skBiuNNcc452PT_jhhH07i8-6PKdlf9u9d0m2MQ3I0uSq_Vlm91eBb2GY4JUCpCaFJQ0g8h4DU42nr0l40G_FEY-btKdg1yMfkLvo3Zo3dbFmmO66ub0Jc_55dXLpP90i9xdupuprNZ3-ZqJGj8jDDlvSg1YZHpM7xm2TzePOe75NdsYtT3W9R09XYVflHt2h4xWDdf2EzDBrLzIo5JmhubvI07wq6ZWZKlec4-aYl7RL8EPnbTJ7EC8tLJQaqmArq6HIUF1rAOfYRddY14BsqXJZ936lKHoOyqdkMvp6-vnQ71Iz-BoQRuUbAFqpSFkaWZVkCZLgaR2xSKdqaK2KbaaEYlazJFE8Q0wV28FABUZokQQ6ip6RDVc484LQVLHYDDhPuYWzECAWOzSCG6QiVAHLmEeCXi5Sd7zlmD5jKleMyyhKCaLE91D-9MinZZNZS9pxW-UPIGx5qXOJVNv4PC_k5VzCgeJIhqIJJvbI-14XJKw_nBrlTLEoJXIrRxz9V3-vg5T_Q4RK8DPPW_1ZjgvglkhgNj2SrGnWsgIOav2Lyy8aHnA46YkgEh7Z7XVQdhtQedvv7i7V9N-T8_K_-n5HNsdfRvLH0cn3V-RBiGurua33mmxU84V5A_CtSt82S_QX4Gg9jQ |
linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELba7QE48C6ElwxCPdBmyebhJMcKtSpIVHvoSuVkOY69jXbrrDZZ0fDrmclruwWKEKfIsRMlkxn7c2bmG0LeewoWBhYAcpORtn0ApTagBN9W2gkVE5JJhvnOX0_ZycT_ch6cb5GjLhemjnbvXJJNTgOyNJny4yLV17z6xch1QwwqQHJSMOqrIfRvkx2GfqYB2Zmcjg-_1f9XAs8G0B7X3uWQgUFFrPNu1il0N-6zsT5tm6X-HfT8NYKyd6PeI3dWZiGq72I-v7ZSHT9oIkqKmuAQA1Rmw1WZDOWPG_SP_y2Eh-R-i2XpYaN8j8iWMo_J3rghw64O6Nk6t6s4oHt0vKbJrp6QBZYGRpqGLFU0MxdZkpUFvVRzYfIpzsBZQdsqQnSppm2ZMZprOKuogPmyglOKykrCDgBv0V4sK4DPVJi0bV8Kiu6J4imZHB-dfTqx2_oPtgQYU9oK0FwSJ37iaRGmITLtSen5nkxEpLUIdCpi4Wvph6FgKQK3QI9GwlGxjENHet4uGZjcqOeEJsIP1IixhGnYcAEs0pGKmUK-Q-H4qW8Rp_vqXLbk6FijY87XtM4oaw6yxrbLryzyob9k0TCD3Db4HagSn8mMI583Hqc5ny057Fo-czeuM5Yt8rbTNA5GjqIRRuWrgiOBs8fQSfbnMVhXIEI8Bi_zrNHO_rkA08UhSNMi4Ybe9gPwoTZ7THZRk43DdjJ2vNgi-51C8naWK2573f3eCP4unBf_NPolueuixtdxgK_IoFyu1GsAhmXypjX7n1VzXHc |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Finasteride+inhibits+melanogenesis+through+regulation+of+the+adenylate+cyclase+in+melanocytes+and+melanoma+cells&rft.jtitle=Archives+of+pharmacal+research&rft.au=Seo%2C+Jae+Ok&rft.au=Yumnam%2C+Silvia&rft.au=Jeong%2C+Kwang+Won&rft.au=Kim%2C+Sun+Yeou&rft.date=2018-03-01&rft.pub=Pharmaceutical+Society+of+Korea&rft.issn=0253-6269&rft.eissn=1976-3786&rft.volume=41&rft.issue=3&rft.spage=324&rft.epage=332&rft_id=info:doi/10.1007%2Fs12272-018-1002-x&rft.externalDocID=10_1007_s12272_018_1002_x |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0253-6269&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0253-6269&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0253-6269&client=summon |